Inovio Pharmaceuticals (INO) Change in Receivables (2010 - 2025)

Inovio Pharmaceuticals has disclosed Change in Receivables across 16 years of filings, most recently posting $138278.0 for Q3 2025.

• In Q3 2025, Change in Receivables rose 55.24% year-over-year to $138278.0; the TTM figure through Sep 2025 stood at -$884149.0 (down 214.13% YoY), while the FY2024 annual figure was -$1.2 million, up 87.08% from the prior year.
• Change in Receivables came in at $138278.0 for Q3 2025 at Inovio Pharmaceuticals, up from -$469925.0 in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $3.9 million in Q2 2022 to a low of -$8.8 million in Q1 2021.
• Average Change in Receivables over 5 years is -$951850.5, with a median of $81120.0 recorded in 2023.
• Year-over-year, Change in Receivables slumped 14969.06% in 2021 and surged 103.0% in 2024.
• Over 5 years, Change in Receivables stood at $906955.0 in 2021, then jumped by 82.76% to $1.7 million in 2022, then sank by 84.25% to $261033.0 in 2023, then plunged by 354.25% to -$663683.0 in 2024, then soared by 120.83% to $138278.0 in 2025.
• Per Business Quant data, the three most recent Change in Receivables figures were $138278.0 in Q3 2025, -$469925.0 in Q2 2025, and $111181.0 in Q1 2025.